Skip Navigation and Go To Content

Giuseppe Buda De Cesare, PhD


Dr. Buda De Cesare attended his bachelor degree in biotechnology at the University of Palermo, Italy, where graduated in 2013. He obtained his master degree in industrial biotechnology at the University of Palermo and FHNW University in Basel, Switzerland, in 2016, working on cell-surface display in bacteria and yeast. He then pursued his PhD studies at the University of Aberdeen, UK, working on proteomic biomarkers for drug resistant Candida species. He graduated in 2020. In the same year, he joined the Lorenz lab at UTHealth as a postdoctoral research fellow. (


PhD, University of Aberdeen (UK), 2020

MSc, University of Palermo, 2016

BSc, University of Palermo, 2013


Michael Lorenz, PhD

Research Description

Dr. Buda De Cesare studies Candida albicans, an opportunistic human fungal pathogen, cause of systemic and superficial infections, especially in immunocompromised patients. Treatment of fungal infections is complicated by limited antifungal options and the development of drug resistance. The aim of Dr. Buda De Cesare is to unveil the molecular mechanism behind the activity of EntV, a bacteriocin and antimicrobial peptide produced by Enterococcus faecalis on C. albicans. Its development as a therapeutic addition to the classical antifungal agents can tackle the problem of drug resistance.